Increased Risk of Acute Pancreatitis in Patients with Type 2 Diabetes: An Observational Study Using a Japanese Hospital Database

被引:61
|
作者
Urushihara, Hisashi [1 ]
Taketsuna, Masanori [2 ]
Liu, Ying [3 ]
Oda, Eisei [4 ]
Nakamura, Masaki [5 ]
Nishiuma, Shinichi [3 ]
Maeda, Rei [3 ]
机构
[1] Kyoto Univ, Dept Pharmacoepidemiol, Grad Sch Med & Publ Hlth, Kyoto, Japan
[2] Eli Lilly Japan KK, Asia Pacific Stat Sci, Kobe, Hyogo, Japan
[3] Eli Lilly Japan KK, Global Patient Safety Japan, Kobe, Hyogo, Japan
[4] Med TOUKEI Corp, Shinjuku Ku, Tokyo, Japan
[5] Med Data Vis Co Ltd, Business Dev Dept, Chiyoda Ku, Tokyo, Japan
来源
PLOS ONE | 2012年 / 7卷 / 12期
关键词
POPULATION-BASED COHORT; ANTIDIABETIC DRUGS; EXENATIDE; EPIDEMIOLOGY; ASSOCIATION; SITAGLIPTIN; MANAGEMENT; GLYBURIDE; THERAPIES; MELLITUS;
D O I
10.1371/journal.pone.0053224
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Increased risks of acute pancreatitis in patients with type 2 diabetes mellitus have been reported recently in several countries. We aimed to estimate the risks of acute pancreatitis in Japanese patients with diabetes mellitus. Methods/Findings: We examined a large-scale hospital administrative database consisting of one million patients in 16 secondary medical care hospitals, from 2003 to 2010. The incidence rates of acute pancreatitis were estimated with cohort design; the odds ratios associated with diabetes mellitus and other comorbid risk factors were estimated with separate case-control analyses. In cohort analysis, the incidence of acute pancreatitis was higher in 14,707 diabetic patients than in 186,032 non-diabetic patients (4.75 vs. 1.65 per 1,000 patient-years) and increased in male patients and as age advanced. The adjusted odds ratio of acute pancreatitis in patients with diabetes mellitus was 1.86 (P<0.001) compared with non-diabetic patients in case-control analysis from 1,372 cases and 5,469 matched controls, which is consistent with the ones reported in previous studies. Alcoholism and gallstones were associated with a large increase in the risk of acute pancreatitis (adjusted odds ratio 13.40 and 14.29, respectively, P<0.001), although dyslipidemia was associated with significant risk reduction (adjusted odds ratio 0.62, P<0.001). Conclusions: This observational study ascertained the elevated incidence rates and risk of acute pancreatitis in Japanese patients with diabetes. The risk estimates in Japanese patients with diabetes were in agreement with the ones reported in previous studies, and the elevated risk of acute pancreatitis in patients with diabetes would be generalized in different locations/populations.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients: A Nationwide Cohort Study
    Chang, Chia-Hsuin
    Lin, Jou-Wei
    Chen, Shu-Ting
    Lai, Mei-Shu
    Chuang, Lee-Ming
    Chang, Yi-Cheng
    MEDICINE, 2016, 95 (07) : e2603
  • [42] Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes
    Johnson, J. A.
    Pollak, M.
    DIABETOLOGIA, 2010, 53 (10) : 2086 - 2088
  • [43] Association Between Severe Hypoglycemia and Cardiovascular Disease Risk in Japanese Patients With Type 2 Diabetes
    Goto, Atsushi
    Goto, Maki
    Terauchi, Yasuo
    Yamaguchi, Naohito
    Noda, Mitsuhiko
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (03):
  • [44] Dietary Survey of Japanese Individuals with Type 2 Diabetes Mellitus on a Low-Carbohydrate Diet: An Observational Study
    Inaba, Sakiko
    Shirai, Tomomi
    Sanada, Mariko
    Miyashita, Hiroyuki
    Inoue, Gaku
    Nagahisa, Taichi
    Wakana, Noriaki
    Homma, Kazuhiro
    Fukuyama, Naoto
    Yamada, Satoru
    NUTRIENTS, 2024, 16 (11)
  • [45] Increased Risk of Myocardial Infarction in Depressed Patients With Type 2 Diabetes
    Scherrer, Jeffrey F.
    Garfield, Lauren D.
    Chrusciel, Timothy
    Hauptman, Paul J.
    Carney, Robert M.
    Freedland, Kenneth E.
    Owen, Richard
    True, William R.
    Lustman, Patrick J.
    DIABETES CARE, 2011, 34 (08) : 1729 - 1734
  • [46] Increased Risk of Falls, Fall-related Injuries and Fractures in People with Type 1 and Type 2 Diabetes - A Nationwide Cohort Study
    Rasmussen, Nicklas H.
    Dal, Jakob
    van den Bergh, Joop
    de Vries, Frank
    Jensen, Morten Hasselstrom
    Vestergaard, Peter
    CURRENT DRUG SAFETY, 2021, 16 (01) : 52 - 61
  • [47] Evaluating the Immunopathogenesis of Diabetes After Acute Pancreatitis in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study From the Type 1 Diabetes in Acute Pancreatitis Consortium
    Casu, Anna
    Grippo, Paul J.
    Wasserfall, Clive
    Sun, Zhaoli
    Linsley, Peter S.
    Hamerman, Jessica A.
    Fife, Brian T.
    Lacy-Hulbert, Adam
    Toledo, Frederico G. S.
    Hart, Phil A.
    Papachristou, Georgios, I
    Bellin, Melena D.
    Yadav, Dhiraj
    Laughlin, Maren R.
    Goodarzi, Mark O.
    Speake, Cate
    PANCREAS, 2022, 51 (06) : 580 - 585
  • [48] Severe hypoglycaemia among patients with type 2 diabetes requiring emergency hospital admission: The Hypoglycaemia In Portugal Observational Study-Emergency Room (HIPOS-ER)
    Conceicao, Joao
    Dores, Jorge
    Arujo, Francisco
    Laires, Pedro A.
    Carr, Richard D.
    Brodovicz, Kimberly
    Radican, Larry
    Nogueira, Ana M.
    DIABETES OBESITY & METABOLISM, 2018, 20 (01) : 50 - 59
  • [49] Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes
    Heaton, Pamela C.
    Desai, Vibha C. A.
    Kelton, Christina M. L.
    Rajpathak, Swapnil N.
    BMC ENDOCRINE DISORDERS, 2016, 16
  • [50] Risk of acute pancreatitis among new users of empagliflozin compared to sulfonylureas in patients with type 2 diabetes: A post-authorization safety study
    Farsani, Soulmaz Fazeli
    Iglay, Kristy
    Zhang, Ling
    Niyonkuru, Christian
    Nessralla, Laurieann
    Girman, Cynthia J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (05)